GC
RAIN

GMT Capital’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

GMT Capital’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-824,865
Closed -$7.21M – 104
2023
Q1 		$7.21M Buy
824,865
+178,607
+28% +$1.65M 0.28% 46
2022
Q4 		$5.17M Buy
+646,258
New +$4.06M 0.24% 49

Other funds holding RAIN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

GMT Capital's RAIN Position: Q2 2023 in Review

GMT Capital sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 824,865 shares — an estimated $7.21M sold.

GMT Capital first reported a position in RAIN in Q4 2022 and held it in 2 quarters. The position peaked at $7.21M in Q1 2023. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • GMT Capital reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • GMT Capital sold 824,865 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $7.21M.
  • GMT Capital first reported a position in Rain Oncology Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • GMT Capital's Rain Oncology Inc. Common Stock position peaked at $7.21M in Q1 2023.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on GMT Capital's 13F filing for Q2 2023, filed 10 Aug 2023.